Authors' Reply.

J Mol Diagn 2018 03;20(2):266

INSERM U1245 Team 03, Centre Henri Becquerel, Rouen; Department of Biological Hematology, Rouen University Hospital, Rouen.

Authors' Reply to the Letter to the Editor by Y. Lynn Wang (MYD88 mutations and sensitivity to ibrutinib therapy).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2017.12.001DOI Listing
March 2018

Publication Analysis

Top Keywords

authors' reply
8
editor lynn
4
lynn wang
4
wang myd88
4
myd88 mutations
4
mutations sensitivity
4
letter editor
4
sensitivity ibrutinib
4
reply letter
4
reply authors'
4
ibrutinib therapy
4
authors'
2
sensitivity
1
ibrutinib
1
therapy
1
wang
1
letter
1
reply
1
editor
1
lynn
1

Similar Publications